In recent decades, we’ve seen tremendous advances in understanding acute myeloid leukemia. In the next five years, emerging treatments and targeted therapies can help save more lives and improve outcomes for so many Canadians.
If you or your loved one are newly diagnosed, in treatment or navigating life after acute myeloid leukemia, join us for an interactive webcast with Dr. Joseph Brandwein on September 29th 2020 at 3:00pm MDT (5:00 pm EDT).
Dr. Brandwein will discuss research innovation and emerging treatments for acute myeloid leukemia and the risk factors for the disease.
Joseph Brandwein, MD, FRCPC
Dr. Brandwein is a clinical hematologist, Director of the Division of Hematology and Professor of Medicine at the University of Alberta. He obtained his MD from McGill University, followed by internal medicine residency at Dalhousie University, hematology residency at Vancouver General Hospital and a leukemia/autologous BMT fellowship at the Toronto General Hospital. He worked for over 13 years in the Leukemia Program at Princess Margaret Cancer Centre in Toronto and has been involved in clinical and translational research in acute leukemia for many years, with over 150 publications.
This webcast was made possible thanks to the support of Abbvie